Books and Research Papers Citing DrugPatentWatch

Sign up for DrugPatentWatch Today

Trial RequestSee Plans and Pricing

2024 — 6 Books and Research Papers Citing DrugPatentWatch

Comments Re: Draft Guidance Considering Exercise of March-In Rights-Docket No.: 230831-0207
FD Ledley, E Zhou - 2024 -

Handbook of Biological Therapeutic Proteins: Regulatory, Manufacturing, Testing, and Patent Issues
S Niazi - 2024 -

Considering Returns on Federal Investment in the Negotiated “Maximum Fair Price” of Drugs Under the Inflation Reduction Act: an Analysis
EW Zhou, PG Chaves da Silva, D Quijada… - Institute for New …, 2024 -

AD Sandhu - Santa Clara High Technology Law …, 2024 -

Biosimilars Development Strategies: Fast to Market Approaches
SK Niazi - 2024 -

Драйвер для инноваций
Ю Василишина - Наука и инновации, 2024 -

2023 — 18 Books and Research Papers Citing DrugPatentWatch

NIH funding for patents that contribute to market exclusivity of drugs approved 2010–2019 and the public interest protections of Bayh-Dole
FD Ledley, EG Cleary - PLoS One, 2023 -

Response to Department of Commerce, National Institute of Standards and Technology, Agency Information Collection Activities
FD Ledley - 2023 -

The Relevance of Regional Specificities of Intellectual Property Regulations for Pharmaceutical Industries: Brazilian Law Changes That Immediately Affected Crucial …
TDME de Almeida, T Paes, D Cordeiro… - Medical Research …, 2023 -

A Cost-Benefit Analysis of the Medicines Patent Pool
LX Wang - Forthcoming in: Economics Bulletin, Max Planck …, 2023 -

Procurement institutions and essential drug supply in low and middle-income countries
LX Wang, NB Zahur - Procurement Institutions and Essential Drug Supply in …, 2023 -

Mandatory Infringement
C Duan - Fla. L. Rev., 2023 - HeinOnline

Public money, public goods? The Bayh Dole Act and its “manufactured substantially” provision
SJS Smith - 2023 -

Computer-aided drug design-based system pharmacology applications for the treatment of diabetes mellitus
S Bibi, MM Hasan, MS Hossain, MS Khan… - … Approaches in Drug …, 2023 - Elsevier

The Economic Burden of Heart Failure with Reduced Ejection Fraction: Living Longer but Poorer?
LA Allen, EF Lowe, DD Matlock - Cardiology Clinics, 2023 -

Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers
E de Pablo, P O'Connell, R Fernández-García… - International Journal of …, 2023 - Elsevier

Do financial literacy and entrepreneurial skills lead to improved performance? Evidence from Swiss Biotechnology sector.
C Santos, H Freire - Journal of Commercial Biotechnology, 2023 -

Nano therapy Spotlight: Arestin™ Minocycline Microspheres. Chem Pharm Res. 2023; 5 (1): 1-8
D Plemmons, KB Sneed, Y Pathak - Correspondence: Yashwant Pathak … -

Recent advances in industrial applications of seaweeds
S Polat, M Trif, A Rusu, V Šimat, M Čagalj… - Critical reviews in …, 2023 - Taylor & Francis

The Importance of Considering Price Metrics and Market Dynamics in US Economic Evaluations: The Case of SGLT-2 Inhibitors in the Treatment of Type 2 …
M Willis, C Neslusan, A Nilsson -

Linking access to finance and governance structure with financial performance of biotechnology firms: the mediation of financial literacy.
L Gabriele, V David - Journal of Commercial Biotechnology, 2023 -

Heart failure with reduced ejection fraction, An Issue of Cardiology Clinics, E-Book: Heart failure with reduced ejection fraction, An Issue of Cardiology Clinics …
A Ghafoor - 2023 -

Emerging role of Machine Learning in field of Pharmacology
P Rajput, A Pramanik, N Yamsani - … Conference on Advanced …, 2023 -

Шляхи та методи забезпечення конкурентоспроможності фармацевтичної продукції АТ «Фармак» на зовнішньому ринку
ЄС Іванова - 2023 -

2022 — 22 Books and Research Papers Citing DrugPatentWatch

Six drugs facing key patent expirations and potential generic entry from May to June 2022
Y Friedman - Pharmaceutical Patent Analyst, 2022 - Future Science

Global drug diffusion and innovation with the medicines patent pool
LX Wang - Journal of Health Economics, 2022 - Elsevier

AI (Re) Defining Pharmaceutical ExclusivitiesJ Kimball, S Ragavan - Biotechnology Law Report, 2022 -

Essential Medicines and Patent on the World Health Organization Essential Medicines List 22nd Edition (2022)
M Schultz - Geneva Network, May, 2022 -

Vasopressin: The Impact of Predatory Patents on a Captive ICU Marketplace
LKN Peterson, JW Devlin - Critical Care Medicine, 2022 -

Noticing Patents
JR Thomas - Colum. Sci. & Tech. L. Rev., 2022 - HeinOnline

Pharma Patent Valuation
R Moro-Visconti - … Corporate Valuation: From Digital Networking to ESG …, 2022 - Springer

Overlap of Trademarks with Other Intellectual Property Rights: The Strategies of Global Brands
MD Selvakumar - Beijing L. Rev., 2022 - HeinOnline

Patent Linkages and Its Impact on Access to Medicines: Challenges, Opportunities for Developing Countries
KD Raju - Access to Medicines and Vaccines: Implementing …, 2022 -

Direct-to-consumer teledermatology growth: a review and outlook for the future
V Ranpariya, D Kats, JB Lipoff - Cutis, 2022 -

Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and …
FW Thielen, RJSD Heine, S van den Berg… - Cytotherapy, 2022 - Elsevier

The coming of age of biosimilars: a personal perspective
SK Niazi - Biologics, 2022 -

How Compounding Pharmacies Fill Critical Gaps in Pediatric Drug Development Processes: Suggested Regulatory Changes to Meet Future Challenges
RB MacArthur, LD Ashworth, K Zhan, RH Parrish - Children, 2022 -

S Mishra, R Kumar - 2022 -

Chronopharmacology of immune-related diseases
S Ohdo, S Koyanagi, N Matsunaga - Allergology International, 2022 -

CK SINGH - 2022 -

Medtech and Biotech Valuation
R Moro-Visconti - … Corporate Valuation: From Digital Networking to ESG …, 2022 - Springer

Patent Philanthropy
H Sun - Cornell Int'l LJ, 2022 - HeinOnline

Astrazeneca equity research-adapting to a dynamic pharmaceutical sector as a key to success
A Papp - 2022 -

Astrazeneca equity research-big pharma on the brink of future changes in oncology
JK Kerkow - 2022 -

РНТБ–45 лет на службе науке и производству. Информационно-ресурсное обеспечение научно-исследовательской деятельности
НС Шалыгина - Научные и технические библиотеки, 2022 -

Implementación del “linkage farmacéutico” en Chile.¿ A qué nos obliga el Tratado Integral y Progresista de Asociación Transpacífico?
PA Viollier Bonvin, S Valenzuela Pulgar - Revista de derecho …, 2022 - SciELO Chile

2021 — 20 Books and Research Papers Citing DrugPatentWatch

Better than a compromise, a third way: Using patent pooling to accelerate access to vaccines and treatments against Covid-19
E Billette de Villemeur, V Dequiedt… - Available at SSRN …, 2021 -

Medicines Patent Pool and HIV Drug Cocktail Diffusion and Innovation
LX Wang - Academy of Management Proceedings, 2021 -

Global Drug Diffusion and Innovation with the Medicines Patent Pool
LX Wang - Available at SSRN 3426554, 2021 -

Is Drug Patent Protection a Determinant of the Location of Pharmaceutical FDI? China's Experience
N Yacoub, H Souei - Innovation, Catch-up and Sustainable Development …, 2021 - Springer

Pharmaceutical opioid marketing and physician prescribing behavior
S Beilfuss, S Linde - Health Economics, 2021 - Wiley Online Library

Affordable Medicines and Innovation: Consequences and Lessons from Countries with Different Patentability Standards
P Vimalnath, O Gurgula, N Scott-Ram… - Bio-Science Law …, 2021 -

A Prescription for America's Prescriptions
H Gintis - Emory Int'l L. Rev., 2021 - HeinOnline

Do current radical innovation measures actually measure radical drug innovation?
I Stiller, A van Witteloostuijn, B Cambré - Scientometrics, 2021 - Springer

Response to proposed rulemaking on Bayh Dole
FD Ledley - 2021 -

RM Visconti - 2021 -

Access to medicinal products

Abuse-deterrent opioid formulations and the opioid crisis: a pharmacist's perspective
S Gadd, N Cox, J Samuelson, A Kenney… - Therapeutic Drug …, 2021 -

Beefing up Skinny Labels: Induced Infringement as a Question of Law
GT Potter - Notre Dame L. Rev., 2021 - HeinOnline

Post COVID-19 Supply Chain Optimization for the Indian Pharmaceutical Industry using AI Techniques
P Shah - Intersect: The Stanford Journal of Science, Technology …, 2021 -

Palonosetron versus ondansetron for prophylaxis of postoperative nausea and vomiting in laparoscopic cholecystectomy: a non-inferiority randomized …
FJC Davolos, NS Modolo, LG Braz… - Brazilian Journal of …, 2021 - Elsevier

Simultaneous automated image analysis and Raman spectroscopy of powders at an individual particle level
A Sekulovic, R Verrijk, T Rades, A Grabarek… - … of Pharmaceutical and …, 2021 - Elsevier

The valuation of pharma patents
R Moro Visconti - Available at SSRN, 2021 -

Centrifuged-concentrated intravitreal slurry triamcinolone acetonide: An inexpensive, easy, and viable alternative to long-term steroid delivery
SM Malinowski, JA Wasserman - Journal of VitreoRetinal …, 2021 -

The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma
JP MacEwan, I Majer, JW Chou… - Therapeutic Advances …, 2021 -

Mieux qu'un compromis, une troisième voie: le panier de brevets pour accélérer l'accès aux vaccins et traitements contre la COVID-19
EB de Villemeur, V Dequiedt, B Versaevel - Revue d'économie du …, 2021 -

2020 — 36 Books and Research Papers Citing DrugPatentWatch

Two drugs facing key patent expirations and potential generic entry from November 2020 to December 2020
Y Friedman - Pharmaceutical Patent Analyst, 2020 -

Three drugs facing key patent expirations and potential generic entry from June 2020 to July 2020
Y Friedman - Pharmaceutical Patent Analyst, 2020 -

Three drugs facing key patent expirations and potential generic entry from September to October 2020
Y Friedman - Pharmaceutical Patent Analyst, 2020 -

Identification of US-pharmaceutical patents expiring between 2018 and 2022 and their effect on the Brazilian domestic market
TDM Paes, LF Aguiar, TD Martins - World Patent Information, 2020 - Elsevier

Essential Medicines and Patents: Recent Trends in the Latest Editions of the World Health Organization's Essential Medicines List
M Schultz, J McDole -

Two drugs facing key patent expirations and potential generic entry from July to August 2020
Y Friedman - Pharmaceutical Patent Analyst, 2020 - Future Science

Government as the first investor in biopharmaceutical innovation: Evidence from new drug approvals 2010–2019
E Cleary, MJ Jackson, F Ledley - Institute for New Economic …, 2020 -

Five drugs facing key patent expirations and potential generic entry from April to May 2020
Y Friedman - Pharmaceutical Patent Analyst, 2020 - Future Science

Weak links: Instabilities and areas for improvement in the drug supply chain
LM Anson, K Taylor - Journal of the American Pharmacists Association, 2020 - Elsevier

Access to essential medicines to guarantee women's rights to health: The pharmaceutical patents connection
JHM Mike - The Journal of World Intellectual Property, 2020 - Wiley Online Library

Societal and economic impact of Accelerator Mass spectrometry
S van der Schans - 2020 -

Perspective, perceptions, and promulgation of biosimilars: A questionnaire-based study to assess and understand the current challenges of biosimilars to the …
KK Bhardwaj, K Bangarurajan, T Naved… - Journal of Pharmacy & …, 2020 -

Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation
AV Nikitina, FV Gorkavenko… - …, 2020 -

The effectiveness of the Swiss and Canadian antibiotic distribution system compared
S Janett - 2020 -

Identifying and Averting the Difficulties in Converting Biotechnological Innovations into Successful Commerce: Case of Bahrain.
AI Al-Alawi, YF El-Tony, EI AlAlawi… - Arab Gulf Journal of …, 2020 -

Potential Impact of Provisions of Intellectual Property Rights Related to the Pharmaceutical Sector in the Comprehensive and Progressive Agreement for Trans-Pacific …
TM Le - MIPLC Master Thesis Series (2019/20), 2020 -

Caps on Capsules: Prescription for Lower Drug Prices in the United States
C Chasse - Food & Drug LJ, 2020 - HeinOnline

Process Intensification for Pharmaceutical Granules Preparation Using Spherical Agglomeration
CW Chen - 2020 -

Biosimilar's Growth in Pharmerging Markets: An Analysis of the Regulatory Environments
R Batel - 2020 - University of the Western Cape

Sentiments Analysis of the Medical or Pharmacy Shops Business to Develop in Terms of Communication, Productivity & Efficiency in Their Retails Business
RD Jadhav, DMS Kadam - Journal of University of Shanghai for Science and … -

Protecting and Securing Data Through Blockchain Across Industries
S Kendzierskyj, H Jahankhani - CYBER SECURITY …, 2020 - World Scientific

Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment–Elevation Myocardial Infarction in the United States: A Study From the National Cardiovascular …
KF Faridi, KN Garratt, KF Kennedy… - … Quality and Outcomes, 2020 - Am Heart Assoc


Pulling the Wrong Lever Opens a Trap Door: Using Taxes to Fight the Opioid War
MM Kwon - 2020 -

Millennials vs. Cyborgs and Blockchain Role in Trust and Privacy
H Jahankhani, S Kendzierskyj… - Handbook of Research on …, 2020 -

Analytical methods in the clinical phase of development
JD Orr, GL Reid - Specification of Drug Substances and Products, 2020 - Elsevier

Pharmacogenetics in clopidogrel
S Osama - 2020 -

Government as the First Investor in Biopharmaceutical Innovation: Evidence From New Drug Approvals 2010–2019 Ekaterina Galkina Cleary, Matthew J …
FD Ledley - 2020 -

Sitagliptin (Januvia) patent litigation: Another link in the judicial train of 'Proactive Infringement'of patented rights in developing countries
Z Iqbal, S Sadaf - Journal of Generic Medicines, 2020 -

UPLC-MS/MS Determination of GLP-1 Analogue, Liraglutide A Bioactive Peptide in Human Plasma
T Gorella, PMN Rajesh, P Wagh -

Формула практической полезности и эффективности патентного поиска
Н Сафронова - Наука и инновации, 2020 -

Palonosetrona versus ondansetrona para profilaxia de náuseas e vômitos pós-operatórios em colecistectomias videolaparoscópicas. Estudo controlado randomizado …
FJC Davolos - 2020 -

林秀琦 - 2020 -

Los derechos de propiedad intelectual y el acceso a los medicamentos para enfrentar a la COVID-19
FA Gómez - 2020 -

Intersección entre competencia y patentes: Hacia un ejercicio pro-competitivo de los derechos de patente en el sector farmacéutico
MJ Rodríguez Gómez - 2020 -

COVID-19 Tedavisinde Kullanılan İlaçların Biyofarmasötik, Farmakokinetik ve Patent Değerlendirmeleri: Ülkemizde Eşdeğer İlaçların Geliştirilmesindeki Güncel …
DY Usta, ZŞ Teksin - Gazi Medical Journal, 2020 -

2019 — 11 Books and Research Papers Citing DrugPatentWatch

Are Medicine Prices High and Unaffordable after Trips? Evidence from Pharmaceutical Industry in India
S Chaudhuri - Evidence from Pharmaceutical Industry in India …, 2019 -

Healthcare Patient and Clinical Research
S Kendzierskyj, H Jahankhani - … and Clinical Trial: Securing Patient Data, 2019 - Springer

Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk: A Cost Consequence Simulation from PARIS
U Baber, DE Leisman, DJ Cohen… - … Quality and Outcomes, 2019 - Am Heart Assoc

Characterization and solution structure of multi-domain proteins and protein complexes
AV Kulakova - 2019 -

Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare …
N Bennaghmouch, AJWM de Veer… - … Journal-Quality of …, 2019 -

Property in human genetic material: An old legal question for a new technological age
J Pila - The Oxford Handbook of Comparative Health Law …, 2019 -

An evaluation of sodium oxybate as a treatment option for narcolepsy
VC Abad - Expert Opinion on Pharmacotherapy, 2019 - Taylor & Francis

Patent abandonment and subsequent cumulative inventions
W Zheng - 2019 -

The effect of patent expiration on sales of branded competitor drugs in a therapeutic class
J Fujimoto, DM Tien, S Snyder… - Journal of Generic …, 2019 -

Основа научных исследований-информационная база
Н Сафронова, Т Нечаева, О Сонных - Наука и инновации, 2019 -

Оптимизация лекарственного обеспечения пациентов со злокачественными новообразованиями на уровне субъекта Российской Федерации
АВ Никитина, ФВ Горкавенко… - Фармакоэкономика …, 2019 -

2018 — 9 Books and Research Papers Citing DrugPatentWatch

More Than One Decade Of Viagra: What Lessons Can Be Learned From Intellectual Property Rights In The Erectile Dysfunction Market?
CRP Da Veiga, CP Da Veiga, JM Del Corso… - … Property to Promote …, 2018 - World Scientific

Ships in the Night: Resolving Administrative Conflict Between FDA-and Patent-Related Legislation
CA Garcia, J Stroud - Am. UL Rev., 2018 - HeinOnline

From American Acts to CPTPP Rules: the enlightenment to patent linkage reforms in China
S Diao - … on Judicial, Administrative and Humanitarian Problems …, 2018 -

Discovery and development of varenicline for smoking cessation
CJ Jordan, ZX Xi - Expert opinion on drug discovery, 2018 - Taylor & Francis

Precision medicine as a promising tool to empower research in healthcare industry
S Mayank, S Suhani - GSC Biological and Pharmaceutical …, 2018 -

Study on the economic impact of supplementary protection certificates, pharmaceutical incentives and rewards in Europe
C Economics - 2018 -

The Commercilazation of a Noval Antithrombotic Drug
Y Dai - 2018 - Case Western Reserve University

Fuentes de información de patentes y procedimiento para las búsquedas de libertad de acción en Cuba
RG Hernández, MC Gibert - … de Información en Ciencias de la …, 2018 -

Государственные гарантии доступности лекарственных средств в России и за рубежом
ФВ Цомартова - Журнал зарубежного законодательства и …, 2018 -

2017 — 9 Books and Research Papers Citing DrugPatentWatch

Orphan Drug legislation: evaluation of the impact of market exclusivity extension
P Gorry - 2017 -

Measuring exaptation and its impact on innovation, search, and problem solving
P Andriani, A Ali, M Mastrogiorgio - Organization Science, 2017 -

Where Are Drugs Invented, and Why Does It Matter?
Y Friedman - ACS Medicinal Chemistry Letters, 2017 - ACS Publications

Repurposing for Alzheimer's and Parkinson's Diseases
H Mucke - Drug repositioning: approaches and applications for …, 2017 -

Current trend in drug delivery considerations for subcutaneous insulin depots to treat diabetes
PV Jayakrishnapillai, SV Nair… - Colloids and Surfaces B …, 2017 - Elsevier

Diazepam in the treatment of moderate to severe alcohol withdrawal
SJ Weintraub - CNS drugs, 2017 - Springer

The efficacy and safety of 12 weeks of sofosbuvir and ledipasvir versus sofosbuvir, ledipasvir, and ribavirin in patients with chronic hepatitis C, genotype 1 …
W Stokes, C Fenton, F Clement, M James… - Canadian Journal of …, 2017 -

4 Systematic Drug
SN Deftereos, A Persidis, A Persidis… - … and Applications for …, 2017 -

A indústria farmacêutica brasileira ea oferta de medicamentos para o tratamento da insuficiência cardíaca no SUS
JM Araújo - 2017 -

2016 — 5 Books and Research Papers Citing DrugPatentWatch

Moving from preclinical research to development
V Pestonjamasp - Journal of Commercial Biotechnology, 2016 -

Propensity score-based approaches to confounding by indication in individual patient data meta-analysis: non-standardized treatment for multidrug resistant …
GJ Fox, A Benedetti, CD Mitnick, M Pai, D Menzies… - PloS one, 2016 -

Online Appendix for'Delayed Entry Settlements at the Patent Office'
E Hovenkamp, J Lemus - International Review of Law and Economics …, 2016

La twittliste du secteur pharmaceutique
F Deprez - Netsources, 2016 -

Plataformas on-line de vigilancia/inteligencia: caracterización e implementación práctica
Y Benítez Nieto - 2016 -

2015 — 4 Books and Research Papers Citing DrugPatentWatch

Valuation of Novo Nordisk A/S 5th February 2015
JB Barslund - 2015 -

Impact of marketing investments on firm value
M Chaudhuri - 2015 -

Oral anti-diabetic agents-review and updates
PO Osadebe, EU Odoh, PF Uzor - British Journal of Medicine and Medical Research, 2015

Verdivurdering av firmaet Photocure ASA
TH Larsen - 2015 -

2014 — 10 Books and Research Papers Citing DrugPatentWatch

More Than One Decade Of Viagra: What Lessons Can Be Learned From Intellectual Property Rights In The Erectile Dysfunction Market?
CR Pereira Da Veiga… - … Journal of Innovation …, 2014 - World Scientific

The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress?
P Blumenfeld, RM Pfeffer, Z Symon, RB Den… - British journal of …, 2014 -

Alberto Galasso
M Schankerman - 2014 -

Vorapaxar, a Protease-Activated Receptor-1 Antagonist, a Double–Edged Sword!
B Bhandari, B Mehta - Recent Patents on Cardiovascular Drug …, 2014 -

Essays on the Competitive Dynamics of Innovation and Product Quality
MS Mills - 2014 -

Preparation, characterization and biological evaluation of chitosanmoxifloxacin prodrugs for pharmaceuticals
A Semwal, S Ramandeep - Marmara Pharmaceutical Journal, 2014 -

The nature of Asian biopharmaceutical innovation
Y Friedman - Nature biotechnology, 2014 -

Multidimensional LC-MS/MS enables simultaneous quantification of intact human insulin and five recombinant analogs in human plasma
EE Chambers, KJ Fountain, N Smith, L Ashraf… - Analytical …, 2014 - ACS Publications

黄楚珺 - 消费者报道, 2014 -

Terapia sekwencyjna w ostrym bólu pooperacyjnym, z zastosowaniem oksykodonu z naloksonem, w kontekście badań klinicznych.
A Rupniewska-Ładyko… - … & Rescue Medicine …, 2014 -

2013 — 9 Books and Research Papers Citing DrugPatentWatch

Transdermal delivery: product and patent update
H Gupta, RJ Babu - Recent patents on drug delivery & …, 2013 -

The structure and business of biopharmaceutical companies including the management of risks and resources
J Samanen - Introduction to Biological and Small Molecule Drug …, 2013 - Elsevier

Amphotericin B formulations–the possibility of generic competition
DR Serrano, MP Ballesteros… - Pharmaceutical …, 2013 -

Katelyn Sylvester, Megan Rocchio, Nahal Beik & John Fanikos
CEHM Rep -

Biosimilars: an emerging category of biologic drugs for emergency medicine practitioners
K Sylvester, M Rocchio, N Beik, J Fanikos - Current Emergency and …, 2013 - Springer

Repurposed drugs in metabolic disorders
J Finsterer, M Frank - Current Topics in Medicinal Chemistry, 2013 -

RP-HPLC method for the estimation of tamsulosin and solifenacin in bulk and its dosage forms
DS Israel, K Krishnachaitanya… - International Journal of …, 2013 - Citeseer

Formulation and Technology Transfer Studies on Antifungal Injection
D Das - 2013 -

Análise enantiosseletiva da fluvastatina em plasma por eletroforese capilar
JMC Yokoya - 2013 -

2012 — 2 Books and Research Papers Citing DrugPatentWatch

Patent protection policy of the therapeutic groups аngiotensin II receptor antagonists
M Manova, A Stoimenova, L Peikova, P Peikov… - 2012 - … медицинска библиотека, МУ …

Economic analysis of the cost savings after implementation of antibiotic policy in hospital
M Manova, A Savova, A Stoimenova… - 2011 - … медицинска библиотека, МУ …

2011 — 1 Books and Research Papers Citing DrugPatentWatch

Influência da porosidade total do leito na cromatografia preparativa em batelada dos enantiômeros do omeprazol.

2010 — 9 Books and Research Papers Citing DrugPatentWatch

Proactive Planning of the Timing of a Partial Switch of a Prescription to Over‐the‐Counter Drug
GE Fruchter, MK Mantrala - Production and Operations …, 2010 - Wiley Online Library

Patinformatics–an emerging scientific discipline
MK Raturi, PK Sahoo, S Mukherjee… - Available at SSRN …, 2010 -

Patinformatics: An Emerging Scientific Discipline
AK Tiwari, MK Raturi, S Mukherjee, PK Sahoo - SSRN, March, 2010 -

Essay on intellectual property and patent backed financing
C Odasso - 2010 -

Location of pharmaceutical innovation: 2000-2009
Y Friedman - Nature reviews. Drug discovery, 2010 -

Oral Controlled Release‐Based Products for Life Cycle Management
N Davar, S Ghosh - … Design and Drug Delivery: Theory to …, 2010 - Wiley Online Library

Reporting and Interpretation of the CYP2C19 Genotyping Test for Clopidogrel Dosing
SD Brouse, JC Fullerton… - Current …, 2010 -

Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate-and low-cardiovascular-risk individuals for statin therapy
KK Lee, LE Cipriano, DK Owens, AS Go, MA Hlatky - Circulation, 2010 - Am Heart Assoc

Patent analysis: a tool for making strategic business decisions
E Norman - 2010 -

2009 — 2 Books and Research Papers Citing DrugPatentWatch

Dosed without Prescription: Preventing Pharmaceutical
M Wu, D Atchley, L Greer, S Janssen… - … Defense Council (NRDC …, 2009 -

AS. Market Analysis of Currently Available Prescription Drugs
J Zhang, SU Ahmed - 2009 - Association for Business and …

2008 — 5 Books and Research Papers Citing DrugPatentWatch

A United States Market Entry Analysis for a New Medical Device
P Doerfling, S Inouye, L Poznanski - 2008 -

Focus on lowest net cost drug reduces costs for patients, plan sponsors
DH Felthouse - American Health & Drug Benefits, 2008 -

Intellectual property portfolio securitization: an evidence based analysis
M Calderini, MC Odasso - Innovation Studies Working Paper …, 2008 -

ASHP guidelines on medication cost management strategies for hospitals and health systems
JM Hoffman, LJ Koesterer… - Am J Health Syst …, 2008 -

2007 — 2 Books and Research Papers Citing DrugPatentWatch

Assessing decision inputs in drug development between small, early stage companies and big pharma: is there is a difference?
DS Rippy - 2007 -

Nano-based drugs and medical devices: FDA's track record
CH Strickland - Nanotech. L. & Bus., 2007 - HeinOnline

Sign up for DrugPatentWatch Today

Try a free trialSee Plans and Pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.